At its meeting on Tuesday, October12, 2023, Beacon Angels members conducted the following business:

We entertained new funding proposals from the following:

• Zelegent (David Elliot) has developed and launched an FDA-cleared Elevo® Snoring Intervention Set for doctors to treat patients in their offices with Elevoplasty® for mild to moderate snoring.
• RealNose (Nikolas Stefanou) offers AI-trained, bio programmable olfactory sensors that map scent profiles, initially to help doctors detect prostate cancer in patients.

We heard follow-on funding presentations as follows:

• QSM Medical sells diagnostic mail-in kits and instruments to veterinarians. These kits and instruments enable pet owners to obtain diagnostic testing results faster.

NED Medical, developing CombiSphere to co-administer chemoradiotherapy at liver tumor sites and thus lower side effects and improve outcomes; and

myBiometry, offering early warning of asthma attacks up to 20 days in advance using intelligent diagnostics and connected monitoring. They are closing out a round that includes Launchpad Ventures and Cherrystone.